期刊文献+

神经生长因子前体在病理性瘢痕中的表达

Expression of nerve growth factor precursor in pathological scars
原文传递
导出
摘要 目的观察神经生长因子前体(proNGF)在病理性瘢痕中的表达。方法收集增生性瘢痕23例和瘢痕疙瘩20例作为病理性瘢痕组,正常皮肤20例作为对照组,采用免疫组织化学技术检测proNGF在3种组织中的表达和分布,Western blotting检测3种组织中proNGF蛋白表达量的差异。结果 proNGF在正常皮肤、增生性瘢痕和瘢痕疙瘩中的表达均呈阳性,表达位于3种组织的表皮和成纤维细胞,免疫组化结果显示,增生性瘢痕和瘢痕疙瘩中proNGF的阳性表达均低于正常皮肤组织(χ2=8.23,P<0.05;χ2=8.29,P<0.05),Western blotting结果同样显示增生性瘢痕和瘢痕疙瘩中proNGF的蛋白表达量低于正常皮肤组织(t=14.02,P<0.01;t=20.80,P<0.01)。结论病理性瘢痕中proNGF的含量低于正常皮肤,病理性瘢痕组织的增生性可能与proNGF的低表达有关。 Objective To observe the expression of nerve growth factor precursor(proNGF) in pathological scars. Methods A total of 23 hyperplastic scar samples and 20 keloid samples(pathological scar group) and 20 normal skin tissues(control group) were collected. The proNGF expressions were examined with immunohistochemical and Western blotting techniques. Results The proNGF was positively expressed in all three tissue types,especially in epidermal cells and fibroblasts. Immunohistochemical examination indicated that proNGF expression was significantly lower in hyperplastic scars and keloids than in normal skin(χ2= 8. 23,P &lt; 0. 05; χ2= 8. 29,P &lt; 0. 05). Western blotting showed that protein expression of proNGF was markedly lower in hyperplastic scars and keloids than in normal skin(t = 14. 02, P &lt; 0. 01; t = 20. 80,P &lt; 0. 01). Conclusion Compared with normal skin,proNGF expression in pathological scars is significantly lower,suggesting the negative relationship between proNGF expression and scar proliferation.
出处 《山东大学学报(医学版)》 CAS 北大核心 2014年第5期92-95,共4页 Journal of Shandong University:Health Sciences
基金 国家自然科学基金(81171818) 济南科技局课题(201102074)
关键词 神经生长因子前体 病理性瘢痕 皮肤 成纤维细胞 Nerve growth factor precursor Pathological scar Skin Fibroblast
  • 相关文献

参考文献17

  • 1Gauglitz G G, Korting H C, Pavicic T, et al. Hyper- trophic scarfing and keloids:pathomechanisms and current and emerging treatment strategies [ J ]. Mol Med, 2011, 17(1-2) :113-125.
  • 2Bock O, Schmid-Ott G, Malewski P, et al. Quality of life of patients with keloid and hypertrophic scarring [ J ]. Arch Dermatol Res, 2006, 297 (10) :433-438.
  • 3袁瑞红,刘流,赵德萍,徐宏慧,孙家平,王福科,马静.神经生长因子对瘢痕成纤维细胞生物学特征的影响[J].中国组织工程研究与临床康复,2010,14(7):1208-1212. 被引量:6
  • 4Song W, Volosin M, Cragnolini A B, et al. ProNGF induces PTEN via p75NTR to suppress Trk-mediated sur- vival signaling in brain neurons [ J ]. J Neurosci, 2010, 30(46) : 15608-15615.
  • 5Zhu Z, Ding J, Shankowsky H A, et al. The molecular mechanism of hypertrophic scar[ J]. J Cell Commun Sig- nal, 2013, 7(4) :239-252.
  • 6Wagner J A. Therapy of pathological scars [ J ]. J Dtsch Dermatol Ges, 2013, 11 (12) :1139-1157.
  • 7Shih B, Garside E, McGrouther D A, et al. Molecular dissection of abnormal wound healing processes resulting in keloid disease [J].Wound Repair Regen, 2010, 18 (2) :139-153.
  • 8Wolfram D, Tzankov A, PULZL P, et al. Hypertrophic scars and keloids-a review of their pathophysiology, risk factors, and therapeutic management[J]. Dermatol Surg, 2009, 35(2) :171-181.
  • 9姜笃银,付小兵,盛志勇.瘢痕组织愈合中成纤维细胞凋亡抗性及其临床意义[J].中华外科杂志,2006,44(7):496-498. 被引量:16
  • 10Aloe L, Tirassa P, Lambiase A. The topical application of nerve growth factor as a pharmacological tool for hu- man corneal and skin ulcers [J]. Pharmacol Res, 2008, 57 (4) :253-258.

二级参考文献37

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部